|
Arkansas State Profile
|
 |
EC PHARMACY UPDATE
In fall 2006, Planned Parenthood of Arkansas and Eastern Oklahoma established direct pharmacy access to EC by telephone in both states. Individuals do not need to be clients of Planned Parenthood in order to get EC. A health history is taken over the phone and EC is picked up at the Planned Parenthood clinics in Little Rock and Fayetteville or, in Hot Springs, from a local cooperating pharmacist. EC can also be delivered overnight from Planned Parenthood’s pharmacy in Tulsa, OK. Prescriptions are written by Planned Parenthood physicians for women aged 17 and younger.
In 2006, CHOICE Hot Springs, an action board of Planned Parenthood Arkansas and Eastern Oklahoma conducted a survey (DOC-24K) of pharmacists in Hot Springs and Garland counties to determine the availability of EC. While more than half of the pharmacists generally had a favorable attitude about filling EC prescriptions, only two of 28 carried it in stock. Most often, pharmacists cited lack of demand as the reason for not stocking it. Since lawmakers tended to mistakenly perceive EC as an abortifacient, Planned Parenthood concluded that more education was needed and conducted a series of information programs and programs for the general public, pharmacy students and other health professionals.
After EC was approved for over-the-counter sales in August 2006, and about a year after its initial survey, CHOICE Hot Springs conducted a second face-to-face survey of all area pharmacies, seeking to find out whether more pharmacies were now carrying EC and which ones were planning to sell it OTC. CHOICE found that the number of pharmacies carrying EC had increased and several more were planning to carry it over-the counter. Subsequent telephone surveys have indicated 12 pharmacies are now (April, 2007) making it available. This is a dramatic increase from the two that carried it in 2006, but is still fewer than half of the area pharmacies.
Increasing the availability of EC was a major focus of Planned Parenthood’s lobbying efforts in the 2007 session of the Arkansas legislature. To that end, a bill requiring hospitals to inform rape victims of the availability of EC was passed and signed into law. Information about EC is now included in rape kits. The law does not require dispensing EC however and there are no provisions for enforcement in the law. The state health department does not to provide EC in its clinics. CHOICE Hot Springs has established a fund to provide EC to needy rape victims.
CONTACTS
Barbara Hansen
Administrator
CHOICE Hot Springs
Action Board of Planned Parenthood of
Arkansas and Eastern Oklahoma
501-262-2099
bjhandclm@aristotle.net
Dr. Mark Riley
Executive Vice President
Arkansas Pharmacists Association
417 South Victory
Little Rock, AR 72201
501-372-5250
Fax: 501-372-0546
mriley@arpharmacists.org
www.arpharmacists.org
Bradley Planey
Team Leader for Women’s Health
Arkansas Department of Health
4815 W. Markham, Slot 16
Little Rock, AK 72205-3867
501-661-2531
Fax: 501-661-2464
bplaney@healthyarkansas.com
www.healthyarkansas.com
USEFUL LINKS
Arkansas Board of Pharmacy
www.state.ar.us/asbp
Arkansas Pharmacist Association
www.arpharmacists.org
Arkansas General Assembly
www.arkleg.state.ar.us
Arkansas Department of Health
www.healthyarkansas.com
PROTOCOL ENVIRONMENT
Possible Environment: Revision to Existing Authority Required
This state permits collaborative practice agreements or a similar agreement between physicians and pharmacists. However, some modification of existing statutes and/or regulations is required to allow pharmacists to initiate EC for the general community.
Pharmacist initiation of EC would require:
- Revising statute to exempt emergency contraception from patient-specific protocols or to remove the patient-specific requirement, AND
- Promulgating regulations establishing standard protocol for emergency contraception
PHARMACY PRACTICE ACT
Pharmacy Practice Act Regulatory and Statutory Authority
Note: The text presented below has been prepared by the American Pharmacists Association for the Pharmacy Access Partnership and reflects legislation or regulation promulgated as of June 15, 2003.
ARKANSAS
Arkansas distinguishes collaborative “drug therapy management” from “disease state management” and regulates them differently. Under “drug therapy management,” a pharmacist may manage the drug therapy of an individual patient with any disease or diseases under a practitioner’s written protocol (either a patient-specific order or a standing order) if it sets forth:
- the disease(s) and drug(s) involved, and
- the types procedures, activities and decisions authorized.
The pharmacist must document all activities/decisions undertaken, routinely report to the physician, and maintain confidential records for two years. The collaborating professionals must review the protocol annually, which requires no external review.
Thus nothing in state statute or regulation precludes a physician and pharmacist from providing emergency contraception to individual patients under this authority.
Under “disease state management,” pharmacists may manage four conditions – asthma, anticoagulation therapy, diabetes and dyslipidemia – under a patient-specific protocol (see above) or “patient care plan” if he/she.
- Passes two exams and fulfills other requirements to demonstrate all competencies needed to implement a pharmaceutical care plan and obtain a state-approved credential in disease state management
- Has a “distinct and private” area, key references and needed equipment to provide such services, and
- Maintains comprehensive records that are reviewable by the Board.
Arkansas law also authorizes diabetes self-management training by pharmacists (see Ark. Code Ann. §§ 23-79-601- 02, and Ark. Reg. 09-00-0003).
Current law authorizes pharmacists to administer immunizations by any route of delivery to persons over 18 years old. Implementation requires pharmacists to secure a standing order/protocol authorizing the activity, which need not be patient-specific.
Pharmacists (but explicitly not pharmacy technicians) may administer (via any route of delivery) only the following medications to persons over the age of 18:
- immunizations and vaccinations
- allergy medications
- antihyperglycemics
- anti-nausea drugs, and
- vitamins and minerals
pursuant to a physician’s written order which, except for immunizations and vaccinations, must be patient-specific.
Statutory Authority: Provided in the relevant sections of the Pharmacy Practice Act, Ark. Code Ann. §17-92- 101, §17-92-101, 205(a) and 316 (Arkansas State Board of Pharmacy Law Book Pharmacy Practice Act As of: March, 2003)
Regulatory Authority:? Provided in the Board of Pharmacy Regulations governing Prescription Orders to Administer Immunizations, Ark. Reg. 09-00-0002; Drug Therapy Management; Ark. Reg. 09-00-0004; and Disease State Management, Ark. Reg. 09-01-0001-0005. (Adopted 8/19/1999, Revised 8/2001)
ARKANSAS STATUTE
ARKANSAS PHARMACY PRACTICE ACT
§17-92: Pharmacists and Pharmacies
Subchapter 1: General Provisions
§17-92-101.Definitions.
As used in this chapter, unless the context otherwise requires:
. . .
(2) “Credentialing” means the issuance or approval by the Arkansas State Board of Pharmacy of a credential issued to a pharmacist by an agency approved by the board certifying that the pharmacist has met the standards of competency established by the board for disease state management or other pharmacy service necessitating a credential;
. . .
(4)
- (A) “Disease state management” means a strategy which utilizes a team-oriented, multi-disciplinary approach to improve health care outcomes and quality of care, and when possible, control health care cost through management of targeted chronic disease states.
- (B) Disease state management focuses on improving health care from prevention to diagnosis and treatment to on-going follow-up.
- (C) Disease state management will involve, but not be limited to, patient education, self-care techniques, and outpatient drug therapy management pursuant to a patient care plan;
. . .
(10) “Patient Care Plan” means a written course of action, which is patient/physician/pharmacist and disease(s) specific, for helping a patient to achieve outcomes that improve a patient’s quality of life;
. . .
(13) “Pharmacy care” means the process by which a pharmacist in consultation with the prescribing practitioner identifies, resolves, and prevents potential and actual drug-related problems and optimizes patient therapy outcomes through the responsible provision of drug therapy or disease state management for the purpose of achieving any of the following definite outcomes that improve a patient’s quality of life:
- (A) cure of disease;
- (B) elimination or reduction of a patient’s symptomology;
- (C) arresting or slowing a disease process; or
- (D) preventing a disease or symptomology.
. . .
(16)(A) “Practice of pharmacy” means the learned profession of:
- (i)
- a) Dispensing, selling, distributing, transferring, possession of, vending, bartering or in accordance with regulations adopted by the board, administering drugs, medicines, poisons, or chemicals that, under the laws of the United States or the State of Arkansas, may be sold or dispensed only on the prescription and order of a practitioner authorized by law to prescribe drugs, medicines, poisons, or chemicals.
- b) Except in accordance with regulations adopted by the board as recommended by the Medications Administration Advisory Committee, the administration of medications shall be limited to the following classifications of medications: immunizations, vaccines, allergy medications, vitamins, minerals, anti-hyper glycemics, and anti-nausea medications.
- c) The administration of medications shall not include the administration of medications to any person under the age of eighteen (18);
- (viii) Advising and providing information concerning utilization of drugs and devices and participation in drug utilization reviews;
- a. Performing a specific act of drug therapy management or disease state management delegated to a pharmacist for an individual patient based upon a written protocol. or a patient care plan approved by the patient’s physician, who shall be licensed in this state under the Arkansas Medical Practices Act, A.C.A. §§17-95-201 – 17-95-207, 17-95-301 – 17-95-305, and 17-95-401 – 17-95-411.
- b. Drug therapy management shall not include the selection of drug products not prescribed by the physician, unless the drug products are either named in the physician initiated protocol or the physician-approved patient care plan;; and
- (x) Providing pharmacy care . . .
. . .
(C)
- (i) The board may permit pharmacy technicians other than pharmacists or interns to perform some or all of those functions described in board regulations under the direct, personal supervision of a licensed pharmacist pursuant to regulations defining the minimum qualifications of such employees, the ratio of pharmacy technicians to supervising pharmacists, and the scope of the duties, practices, and procedures that the board determines will promote the delivery of competent, professional pharmaceutical services and promote the public health and welfare. Nothing in this chapter shall be construed as allowing pharmacy technicians to administer medications.
(22) “Written Protocol” means a physician’s order, standing medical order, standing delegation order, or other order or protocol as defined by regulation of the Arkansas State Medical Board under the Arkansas Practices Act, §17-95-201– 17-95-207, 17-95-301 – 17-95-305, and 17-95-401 – 17-95-411. .. (b) Except for immunizations and vaccinations, which may be general protocols, protocols shall be patient/physician/pharmacist specific for prescriptions or orders given by the physician authorizing the protocol.
17-92-205. Rules and regulations – Enforcement.
(a) The Arkansas State Board of Pharmacy shall have authority to make reasonable rules and regulations, not inconsistent with law, to carry out the purposes and intentions of this chapter and the pharmacy laws of this state which the board deems necessary to preserve and protect the public health. The Board shall by regulation establish standards for the administration of medications by licensed pharmacists, including, but not limited to, the completion of a course in the administration of medications.
§17-92-316. Credential required for professional pharmacy service.
(a)
- (1) The Arkansas State Board of Pharmacy may provide by regulation for credentialing and approval of pharmacists to practice disease state management and any other pharmacy services determined by the board to require a credential.
- (2)
- (A) The credentials may be issued by agencies approved by the board to pharmacists who qualify pursuant to minimum competencies, standards, objectives, and qualifications determined by the board.
- (B) However, a credential shall not authorize the pharmacist to practice credentialed pharmacy service in Arkansas until after the board has determined that the credentialed pharmacist meets the minimum competencies, standards, objectives, and qualifications determined by the board.
(b) The board shall adopt regulations necessary and appropriate to implement the credentialing and the board’s approval of pharmacists to practice disease state management and other credentialed pharmacy services, including:
- (1) Identification of areas of credentialed pharmacy services;
- (2) Identification of the minimum competencies, standards, objectives, and qualifications necessary for a credential and the board’s approval to practice in each area of credentialed pharmacy service;
- (3) Identification of the standards for qualifying an agency to issue credentials for areas of pharmacy services;
- (4) The procedure and standards, which may include a practical examination, for the board’s review and approval of a credential and determination of a pharmacist’s qualifications to practice disease state management or other credentialed pharmacy service;
- (5) The conversion of a credential previously issued by the board for the practice of disease state management or other pharmacy service to a credential issued by an approved credentialing agency; and
- (6) Continuing professional education and other measures to maintain pharmacists’ continuing competency in disease state management and other credentialed pharmacy services.
(c) The board shall promulgate regulations to:
- (1) Identifying areas of credentialing;
- (2) Establish procedures for initial application and renewal;
- (3) Define the minimum competencies and standards to be examined;
- (4) Define the qualifications for credentialing; and
- (5) Define required continuing education, competencies, standards, and other information necessary to implement this
ARKANSAS REGULATIONS
Board of Pharmacy Regulations
Regulation 9 – Pharmaceutical Care and Patient Counseling
09-00-0002
PRESCRIPTION ORDERS TO ADMINISTER MEDICATION AND/OR IMMUNIZATIONS
(a). MEDICATIONS ADMINISTRATION ADVISORY COMMITTEE:
- 1. The purpose of the Medication Administration Advisory Committee shall include functioning in an advisory capacity to assist the Board with implementation and oversight of the provisions regarding medication administration authority.
- 2. The Medication Administration Advisory Committee shall be composed of five members, to be approved by the Governor, who have the following qualifications:
- a. Two members shall be licensed physicians selected from a list of three names per position submitted jointly by the State Medical Board and the Arkansas Medical Society.
- b. Two members shall be licensed pharmacists-- one pharmacist shall be recommended by the Arkansas Pharmacists Association and one pharmacist shall be a member of the Arkansas State Board of Pharmacy.
- c. One member shall be an advanced practice nurse holding a certificate of prescriptive authority selected from a list of three names submitted jointly by the State Nursing Board and the Arkansas Nurses Association.
- d. The Board may remove any advisory committee member, after notice and hearing for incapacity, incompetence, neglect of duty, or malfeasance in office.
- e. The members shall serve without compensation, but may be reimbursed to the extent special moneys are appropriated therefore for actual and necessary expenses incurred in the performance of their duties.
- 3. The five initial members appointed to the committee shall draw lots to determine staggered lengths of their initial terms. Successive members shall serve three (3) year terms.
(b): AUTHORITY FOR PHARMACIST TO ADMINISTER MEDICATIONS/IMMUNIZATIONS:
- 1. Pharmacists may provide pharmaceutical care to patients over the age of eighteen (18) by administering medications or immunizations to an eligible patient upon a valid prescription order by a practitioner so authorized to prescribe such medications or immunizations. A prescription order for a medication or immunization shall constitute a unique class of prescriptions and shall apply to any person over the age of eighteen (18) desiring a medication or immunization. A prescription from a practitioner for administration, by a pharmacist, of an approved medication or immunization will be known as an “Authority to Administer.”
- 2. An Authority to Administer, once granted, is valid for a time period not to exceed one (1) year--unless such an order is invalidated by the practitioner granting the authority.
- 3. An Authority to Administer is valid only for the pharmacist meeting the requirements set forth by the Arkansas State Board of Pharmacy and is not transferable.
- 4. Unless otherwise specifically authorized, by the Board, a person must possess the following qualifications to be qualified to accept an initial Authority to Administer order:
- a. obtain and maintain a license to practice pharmacy issued by the Arkansas State Board of Pharmacy;
- b. successfully complete a Board approved course of study, examination, and certification consisting of a training program that includes the current guidelines and recommendations of the Centers of Disease Control and Prevention. The Course of study should include, at a minimum:
- (i) basic immunology, including the human immune response;
- (ii) the mechanism of immunity, adverse effects, dose, and administration schedule of available vaccines and approved medication/immunization;
- (iii) how to handle an emergency situation in the event one should arise as a result of the administration of the medication /immunization;
- (iv) how to persuade patients to be immunized and options for record keeping for patients that do get immunized;
- (v) how to administer subcutaneous, intradermal, and intramuscular injection; and
- (vi) record keeping requirements for these medications as required by law or regulation.
- c. obtain supervised instructions on the physical administration of vaccines during such course of study and certification;
- d. obtain and maintain current certification in Cardiopulmonary Resuscitation (CPR) or Basic Cardiac Life Support (BCLS); and
- e. successfully complete the above described course of study which shall be a minimum of 20 hours and shall qualify for continuing education credits. The provider of said course of study shall provide participants a certificate of completion which shall be displayed in the pharmacy at which the pharmacist is working. A copy of said certificate shall be mailed to the Board of Pharmacy offices and placed in the pharmacist's permanent file.
- 5. Continuing competency for certification for Authority to Administer must be maintained. A minimum of one (1) hour of the fifteen (15) hour requirement for continuing education, every year, must be dedicated to this area of practice.
- 6. An Authority to Administer order shall meet the following requirements:
- a. must properly identify the practitioner issuing the order;
- b. must identify the medication or vaccine covered in any such order
- c. must properly identify the patient to receive any medication or immunization, by name, address, age, sex, and date of administration;
- d. must identify the medication or vaccine administered, site of the administration, dose administered, identity of pharmacist administering the dose; and
- e. must bear the date of the original order and the date of each administration.
C. SEVEN CLASSIFICATIONS OF APPROVED MEDICATIONS FOR ADMINISTRATION
- 1. Immunizations
- 2. Vaccines
- 3. Allergy Medications
- 4. Vitamins
- 5. Minerals
- 6. Antihyperglycemics
- 7. Anti-nausea Medications
09-00-0004
DRUG THERAPY MANAGEMENT BY A PHARMACIST UNDER WRITTEN PROTOCOL OF A PHYSICIAN.
The purpose of this regulation is to provide standards for the maintenance of records of a pharmacist engaged in the provision of drug therapy management as authorized in §17-92-101 (14) and §17-92-205 (a).
(a) DEFINITIONS: The following words and terms, when used in this regulation, shall have the following meanings, unless the context clearly indicates otherwise:
- …
- (3) CONFIDENTIAL RECORD -- any health-related record maintained by a pharmacy or pharmacist--such as a patient medication record, prescription drug order, or medication order.
- (4) DRUG THERAPY MANAGEMENT means the performance of specific acts of drug therapy management delegated to a pharmacist for an individual patient by an authorized practitioner through written protocol. (Drug therapy management shall not include the selection of drug products not prescribed by the practitioner, unless the drug product is named in the practitioner initiated protocol.)
- (5) WRITTEN PROTOCOL means a practitioner's order, standing medical order, standing delegation order, or other order or protocol as defined by rule of the Arkansas State Medical Board under the Medical Practice Act.
- (A) A written protocol must contain at a minimum the following:
- (i) a statement identifying the individual practitioner authorized to prescribe drugs and responsible for the delegation of drug therapy management;
- (ii) a statement identifying the individual pharmacist authorized to dispense drugs and to engage in drug therapy management delegated by the practitioner;
- (iii) a statement identifying the types of drug therapy management decisions that the pharmacist is authorized to make which shall include:
- (a) A statement of the ailments or diseases involved, drugs, and types of drug therapy management authorized; and
- (b) A specific statement of the procedures, decision criteria, or plan the pharmacist shall follow when exercising drug therapy management authority;
- (iv) A statement of the activities the pharmacist shall follow in the course of exercising drug therapy management authority, including the method for documenting decisions made and a plan for communication or feedback to the authorizing physician concerning specific decisions made. Documentation shall be recorded within a reasonable time of each intervention and may be performed on the patient medication record, patient medical chart, or in a separate log book; and
- (v) A statement that describes appropriate mechanisms and time schedule for the pharmacist to report to the physician monitoring the pharmacist's exercise of delegated drug therapy management and the results of the drug therapy management.
(B) A standard protocol may be used, or the attending practitioner may develop a drug therapy management protocol for the individual patient. If a standard protocol is used, the practitioner shall record, what deviations if any, from the standard protocol are ordered for that patient.
(C) Maintenance of records:
- (i) Every patient record required to be kept under this regulation shall be kept by the pharmacist and be available, for at least two years from the date of such record, for inspecting and copying by the Board or its representative and to other authorized local, state, or federal law enforcement or regulatory agencies.
- (ii) Patient records may be maintained in an alternative data retention system, such as a data processing system or direct imaging system provided:
- (a) The records maintained in the alternative system contain all of the information required on a manual record; and
- (b) The data processing system is capable of producing a hard copy of the record upon the request of the Board, its representative, or other authorized local, state, or federal law enforcement or regulatory agencies.
(D) Written protocol:
- (i) A copy of the written protocol and any patient-specific deviations from the protocol shall be maintained by the pharmacist and available for inspection by a Board Inspector upon request.
- (ii) Written protocols, including standard protocols, any patient specific deviations from a standard protocol, and any individual patient protocol, shall be reviewed by the practitioner and pharmacist at least annually and revised, if necessary. Such review shall be documented in the pharmacist's records. Documentation of all services provided to the patient, by the pharmacist, shall be reviewed by the physician on the schedule established in the protocol.
- (iii) Any protocol from a practitioner shall be maintained in the pharmacy and available for inspection by a Board Inspector upon request.
(E) Confidentiality:
- (i) A pharmacist shall provide adequate security to prevent indiscriminate or unauthorized access to confidential records. If confidential health information is not transmitted directly between a pharmacy and a practitioner, but is transmitted through a data communication device, the confidential health information may not be accessed or maintained by the operator of the data communication device unless specifically authorized to obtain the confidential information by this regulation.
- (ii) Confidential records are privileged and may be released only to:
- (a) the patient or the patient's agent;
- (b) practitioners and other pharmacists when, in the pharmacist's professional judgment, such release is necessary to protect the patient's health and well-being;
- (c) other persons, the Board, or other state or federal agencies authorized by law to receive such information;
- (d) a law enforcement agency engaged in investigation of suspected violations of the Controlled Substances Act; or
- (e) a person employed by any state agency which licenses a practitioner as defined in the Act if such person is engaged in the performance of the person's official duties.
- (iii) This regulation shall not affect or alter the provisions relating to the confidentiality of the physician-patient communication as specified in the Medical Practice Act.
09-01:
DISEASE STATE MANAGEMENT
09-01-0001
AREAS OF PRACTICE IN DISEASE STATE MANAGEMENT
The Board of Pharmacy will recognize the following areas of practice in Disease State Management. This list may be expanded, as standard exams in other areas become available.
- 1. Asthma
- 2. Anticoagulation Therapy
- 3. Diabetes
- 4. Dyslipidemia
09-01-0002
QUALIFICATIONS, RESOURCES, AND RECORD KEEPING REQUIRED FOR PRACTICING IN A DISEASE STATE MANAGEMENT AREA IN ARKANSAS.
(a. To obtain a credential in an area of disease state management a pharmacist must meet the following qualifications:
- (1) Be a licensed pharmacist in the state of Arkansas
- (2) Achieve a passing score on an examination approved by the Board of Pharmacy that tests for the minimum standards of competency as identified in Section 09-01. Said examination shall be the nationally recognized standard as approved by the Arkansas State Board of Pharmacy.
- (3) Achieve a passing score on an Arkansas State Board of Pharmacy approved practical examination in the area of disease state management.
- (4) Complete requirements for the credential as established by a Board of Pharmacy approved credentialing organization.
(b) Resource requirements for the provision of Disease State Management services shall include-but are not limited to the following:
- (1) Maintain a distinct area that provides privacy for the provision of disease state management services.
- (2) Maintain references that include a current copy/edition of applicable national practice guidelines and such other resources as may be necessary for the provision of optimal care.
- (3) Maintain devices, supplies, furniture, and equipment as may be needed for the provision of optimal care.
(c) Record keeping requirements for Disease State Management.
The pharmacist, holding a credential in Disease State Management, shall record, maintain, and transfer data essential to the continuity of care and consistent with all applicable state and federal laws and regulations; and these records and all related files shall be available to the Arkansas State Board of Pharmacy inspectors and professional staff upon request. Additionally, a transferable pharmaceutical care record is to be maintained and is to include:
- (1) The written request for consultation from the patient's physician.
- (2) The physician approved protocol and/or patient care plan, which is to recognize all concomitant diseases and the patient's complete medication history/profile.
- (3) Pharmacy progress notes.
- (4) Laboratory data.
09-01-0003
MINIMUM COMPETENCIES AND STANDARDS TO BE MET BY THE COMPETENCY EXAMINATIONS FOR DISEASE STATE MANAGEMENT
(a) Minimum Competencies for Pharmaceutical Care in all Disease State Management areas:
- (1) The pharmacist shall be capable of identifying and accessing the patient's current health status, health-related needs and problems, and desired therapeutic outcomes.
- (2) The pharmacist shall be capable of implementing, and evaluating a pharmaceutical care plan that assures the appropriateness of the patient's medication(s), dosing regimens, dosage forms, routes of administration, and delivery systems.
- (3) The pharmacist shall be capable of communicating appropriate information to the patient and/or caregiver and other health care professionals regarding prescription or non-prescription medications and/or medical devices, disease states, or medical conditions, and the maintenance of health and wellness.
- (4) The pharmacist shall be capable of monitoring and documenting the patient's progress toward identified endpoints and outcomes of the pharmaceutical care plan and shall intervene when appropriate.
- Disease state specific competency requirements are revised periodically and are furnished at the time of application for the respective exams or upon request to the Board.
09-01-0004
NOTIFICATION OF CREDENTIAL IN DISEASE STATE MANAGEMENT REQUIRED:
Every pharmacist who receives a credential in disease state management, from a Board approved credentialing agency, must mail a copy of the credential to the Board of Pharmacy Office—along with proof of satisfactory completion of the practical examination. Upon receipt of the credential and acceptable evidence of successful completion of the Board's practical examination, the Board’s Executive Director shall cause the approval of the qualifications for the pharmacist to practice in a disease state management area and the pharmacist shall be qualified to practice in the credentialed disease state management area. The Board of Pharmacy will notify any party requesting notification that the pharmacist is so qualified.
09-01-0005
CONTINUED COMPETENCE
The Arkansas State Board of Pharmacy may require additional training and assessment of pharmacists, who hold a credential in that Disease State. Sufficient notice, by the Arkansas State Board of Pharmacy, shall be given to the pharmacists holding the credential being redefined. (Adopted 8/19/99)(Revised 8/2001)
|
